Adsorbed Acellular Pertussis, Diphtheria, Tetanus Combined Vaccine吸附无细胞百日咳、白喉、破伤风联合疫苗
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 成都生物制品研究所有限责任公司Chengdu Shengwu Zhipin Yanjiu Suoyou Xianze Rengong Si
主要成分Active Ingredients
- 破伤风类毒素Poshang Fenglei Dusu
- 种纯化的百日咳抗原[百日咳类毒素(PT
- 丝状血凝素(FHASizhuang Xuening Su
- KD外膜蛋白(百日咳杆菌粘附素)]按一定比例混合 经氢氧化铝吸附而成 白喉类毒素
- 破伤风类毒素是由白喉毒素Poshang Fenglei Dusu Shiyou Baihou Dusu
- 破伤风毒素经脱毒Poshang Fengdu Sujing Tuodu
- 纯化制成 无细胞百日咳疫苗组份(PTRecorded Chinese composition: 纯化制成 无细胞百日咳疫苗组份(PT
- FHA
- 百日咳杆菌粘附素)制备于百日咳鲍特氏杆菌期培养物 经萃取Recorded Chinese composition: 百日咳杆菌粘附素)制备于百日咳鲍特氏杆菌期培养物 经萃取
- 纯化Chun Hua
- 甲醛处理 PT被不可逆转地脱毒 白喉类毒素Jiaquan Chuli Beibu Keni Zhuandi Tuodu Baihou Leidu Su
- 经氢氧化铝吸附而成Jingqing Yanghua Lvxi Fuer Cheng
- 白喉类毒素和破伤风类毒素是由白喉毒素和破伤风毒素经脱毒及纯化制成Baihou Leidu Suhe Poshang Fenglei Dusu Shiyou Baihou Dusu Hepo Shangfeng Dusu Jingtuo Duji Chunhua Zhicheng
- 无细胞百日咳疫苗组份(PTRecorded Chinese product: 无细胞百日咳疫苗组份(PT
- 经萃取Jingcui Qu
- PT被不可逆转地脱毒Beibu Keni Zhuandi Tuodu
- 白喉类毒素Baihou Leidu Su
- 成品疫苗用生理盐水配制Recorded Chinese product: 成品疫苗用生理盐水配制
- 该疫苗符合世界卫生组织关Recorded Chinese product: 该疫苗符合世界卫生组织关
药物知识说明
破伤风类毒素是一种在国家药监局注册认定的药品。该药品含有相关活性成分。
该药品关联的活性成分包括:pt被不可逆转地脱毒、成品疫苗用生理盐水配制、破伤风毒素经脱毒、破伤风类毒素是由白喉毒素Poshang Fenglei Dusu Shiyou Baihou Dusu、经氢氧化铝吸附而成Jingqing Yanghua Lvxi Fuer Cheng。这些成分信息来自国家药监局数据库。
您可以探索含有相同成分的其他药品:pt被不可逆转地脱毒-a4da8940成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 吸附无细胞百日咳、白喉、破伤风联合疫苗) is a medicine registered with the national drug regulatory authority. It contains active ingredient(s) as recorded.
Active ingredients associated with this product: pt, 破伤风类毒素是由白喉毒素Poshang Fenglei Dusu Shiyou Baihou Dusu, 经氢氧化铝吸附而成Jingqing Yanghua Lvxi Fuer Cheng.
Explore other medicines containing the same ingredient: pt被不可逆转地脱毒 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 吸附无细胞百日咳、白喉、破伤风联合疫苗Adsorbed Acellular Pertussis, Diphtheria, Tetanus Combined Vaccine
- 规格Specification: 0.5ml0.5 mL
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 成都生物制品研究所有限责任公司Chengdu Shengwu Zhipin Yanjiu Suoyou Xianze Rengong Si
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字S10970013
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字S10970013
Manufacturer
Chinese legal name: 成都生物制品研究所有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字S10970013
生产企业
成都生物制品研究所有限责任公司(国产)
适应症
本疫苗接种后,可使机体产生免疫应答,用于预防百日咳、白喉、破伤风。
用法用量
1.臀部外上方1/4处或上臂外侧三角肌附着处皮肤经消毒后肌内注射|2.免疫程序与剂量|基础免疫自3月龄开始,至12月龄完成3针免疫每次0.5ml每针间隔4~6周|加强免疫通常在基础免疫后18~24月龄内进行注射剂量为1.5ml
不良反应
注射本品一般无反应,有的接种部位有轻度红晕、痒感或有低热,一般不须特殊处理,即行消退,如有严重反应及时诊治。
禁忌
1. 有癫痫、神经系统疾病及抽风史者禁用。2. 急性传染病(包括恢复期)及发热者,暂缓注射。
注意事项
1. 使用时应充分摇匀,如出现摇不散之凝块、有异物、安瓿有裂纹、制品曾经冻结、标签不清和过期失效者不可使用。2. 注射后局部可能有硬结,可逐步吸收。注射第2针时应更换另侧部位。 3. 应备肾上腺素,供偶有发生休克时急救用。4. 注射第1针后出现高热、惊厥等异常情况者,不再注射第2针。
规格
0.5ml
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.